Global Spinal Muscular Atrophy (SMA) Treatment Market Report By Type (Type 1, Type 2, Type 3, And Type 4), Treatment (Gene Therapy, And Drug), Route Of Administration (Oral, And Intrathecal) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2018-2025
ID:VMR11210467
February 2019
Report Formats:

As per this study, the Global Spinal Muscular Atrophy (SMA) Treatment Market was valued USD XX.X MN (by revenue) in 2018 and is anticipated to reach USD XX.X MN by 2025 with a CAGR of X.X%.

Spinal Muscular Atrophy (SMA) is a hereditary disease affecting the part of the nervous system that controls voluntary muscle movement. SMA disables people of physical strength by affecting the motor nerve cells of the spinal cord, taking away ability to eat, walk or breathe. It is the genetic cause of infant death globally. SMA affects 1 in 11,000 babies approximately. The only drug approved for the treatment of SMA is Spinraza. An alternative to this, gene therapy is another treatment used to treat SMA.
 
Market Dynamics
 
The increasing awareness by various NGO’s and the public regarding Spinal Muscular Atrophy (SMA) and a growing number of initiatives to improve treatment for rare diseases are fueling the market growth of SMA treatment. Moreover, improving the healthcare sector is again boosting the market growth. However, the high cost of treatment and lack of experienced professionals are some of the factors that restrain market growth. Whereas, innovation of more efficient drugs and therapies is expected to offer opportunities to SMA treatment market in the forecast period.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of spinal muscular atrophy (SMA) treatment.
 
Market Segmentation
 
The broad spinal muscular atrophy (SMA) treatment market has been sub-grouped into type, treatment and route of administration. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Type

  • Type 1
  • Type 2
  • Type 3
  • Type 4
 
By Treatment
  • Gene Therapy
  • Drug
 
By Route Of Administration
  • Oral
  • Intrathecal
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for spinal muscular atrophy (SMA) treatment in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Spinal Muscular Atrophy (SMA) Treatment Market By Revenue (USD MN)
 
Europe Spinal Muscular Atrophy (SMA) Treatment Market By Revenue
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the spinal muscular atrophy (SMA) treatment market includes Avexis, Inc., Biogen, Cytokinetics, Inc., F. Hoffmann - La Roche Ltd, Ionis Pharmaceuticals, Inc., and Novartis AG. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1. INTRODUCTION

  • Introduction To Spinal Muscular Atrophy (SMA) Treatment
  • Report Description
    • Objectives Of The Study
    • Assumptions
  • Research Scope
  • Research Methodology
    • Data Source
 
2. EXECUTIVE SUMMARY
  • Market Highlight
  • Global Spinal Muscular Atrophy (SMA) Treatment Market: Snapshot
 
3. MARKET ANALYSIS
  • Drivers
  • Restraints
  • Opportunities
  • Porter’s Five Forces Analysis
  • Value Chain Analysis
 
4. SPINAL MUSCULAR ATROPHY (SMA) TREATMENT MARKET ANALYSIS BY TYPE
  • Spinal Muscular Atrophy (SMA) Market In Type 1
  • Spinal Muscular Atrophy (SMA) Market In Type 2
  • Spinal Muscular Atrophy (SMA) Market In Type 3
  • Spinal Muscular Atrophy (SMA) Market In Type 4
 
5. SPINAL MUSCULAR ATROPHY (SMA) TREATMENT MARKET ANALYSIS BY TREATMENT
  • Spinal Muscular Atrophy (SMA) Market In Gene Therapy
  • Spinal Muscular Atrophy (SMA) Market In Drug
 
6. SPINAL MUSCULAR ATROPHY (SMA) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
  • Spinal Muscular Atrophy (SMA) Market In Oral
  • Spinal Muscular Atrophy (SMA) Market In Intrathecal
 
7. SPINAL MUSCULAR ATROPHY (SMA) TREATMENT MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.) Market Estimates By Segments
    • Rest Of North America Market Estimates By Segments
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK) Market Estimates By Segments
    • Germany Market Estimates By Segments
    • France Market Estimates By Segments
    • Rest Of Europe Market Estimates By Segments
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China Market Estimates By Segments
    • Japan Market Estimates By Segments
    • India Market Estimates By Segments
    • Rest Of Asia Pacific Market Estimates By Segments  
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil Market Estimates By Segments
    • Rest Of Latin America Market Estimates By Segments
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East Market Estimates By Segments
    • Africa Market Estimates By Segments
 
8. COMPETITIVE LANDSCAPE OF THE SPINAL MUSCULAR ATROPHY (SMA) TREATMENT COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
9. COMPANY PROFILES OF THE SPINAL MUSCULAR ATROPHY (SMA) TREATMENT INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
  • Avexis, Inc.
  • Biogen
  • Cytokinetics, Inc.
  • F. Hoffmann - La Roche Ltd
  • Ionis Pharmaceuticals, Inc.
  • Novartis AG
 
* Tentative TOC
 
LIST OF TABLES
 
Table 1.  Market Highlights Of Spinal Muscular Atrophy (SMA) Treatment
Table 2.  Global Spinal Muscular Atrophy (SMA) Treatment Market By Types
Table 3.  Global Spinal Muscular Atrophy (SMA) Treatment Market By Treatment
Table 4.  Global Spinal Muscular Atrophy (SMA) Treatment Market By Route Of Administration
Table 5.  Global Spinal Muscular Atrophy (SMA) Treatment Market By Geography
Table 6.  North America Spinal Muscular Atrophy (SMA) Treatment Market
Table 7.  Europe Spinal Muscular Atrophy (SMA) Treatment Market
Table 8.  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market
Table 9.  Latin America Spinal Muscular Atrophy (SMA) Treatment Market
Table 10. Middle East And Africa Spinal Muscular Atrophy (SMA) Treatment Market 
Table 11. Partnership/Collaboration/Agreements
Table 12. Mergers And Acquisitions
Table 13. New Product Development
Table 14. Other Developments
  
LIST OF FIGURES
 
Fig. 1.     Market Segmentation Of Spinal Muscular Atrophy (SMA) Treatment Market 
Fig. 2.     Top-Down Approach   
Fig. 3.     Bottom-Up Approach   
Fig. 4.     Market Highlights Of Spinal Muscular Atrophy (SMA) Treatment
Fig. 5.     Porter’s Five Forces Analysis
Fig. 6.     Value Chain Analysis
Fig. 7.     Global Spinal Muscular Atrophy (SMA) Treatment Market By Types
Fig. 8.     Global Spinal Muscular Atrophy (SMA) Treatment Market By Treatment
Fig. 9.     Global Spinal Muscular Atrophy (SMA) Treatment Market By Route Of Administration 
Fig. 10.   Global Spinal Muscular Atrophy (SMA) Treatment Market By Geography
Fig. 11.   North America Spinal Muscular Atrophy (SMA) Treatment Market
Fig. 12.   Europe Spinal Muscular Atrophy (SMA) Treatment Market
Fig. 13.   Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market
Fig. 14.   Latin America Spinal Muscular Atrophy (SMA) Treatment Market
Fig. 15.   Middle East And Africa Spinal Muscular Atrophy (SMA) Treatment Market
Fig. 16.   Market Share Of Spinal Muscular Atrophy (SMA) Treatment Companies
Fig. 17.   Recent Developments In Spinal Muscular Atrophy (SMA) Treatment Industry
 
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.  

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials